AchromoPhage

AXP000240.1 · Phage therapy

Platform
phage cocktail (non-engineered)
Originator
University of Pittsburgh
Sponsor
University of Pittsburgh

Names

NameTypeSource
AchromoPhagepreferred name, codecurator, ctgov

Virus

Role
Phage
Family
Caudoviricetes
Virus
Achromobacter bacteriophage (cocktail)
Replication
replicating
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (1)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT07275905Bacteriophages for Adults With Cystic Fibrosis and Chronic Achromobacter Lung InfectionRecruitingPhase 12026-08-202028-0112Achromobacter Infection; Cystic Fibrosis (CF)

Recent changes

No changes recorded in its trials yet.

Notes

Achromobacter-targeting phage cocktail in a phase 1 pilot trial in people with cystic fibrosis and chronic Achromobacter lung infection (NCT07275905).

How to cite

AchromoPhage (AXP000240.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000240.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.